Production of Nystatin in VUAB Pharma was on 7 - 10 March 2011 successfully audited by the U.S. Food and Drug Administration.
On July 18, 2011 issued SUKL (State Institute for Drug Control) GMP Certificate for manufacturer of active substances: Oxaliplatin CAS 61825-94-3
On February 27, 2012 issued SUKL (State Institute for Drug Control) GMP Certificate for manufacturer of active substances: Dacarbazine CAS 4342-03-4
